Editorial Comment on: Enhanced Recovery After Surgery Protocol for Patients Undergoing Ureteroscopy: Prospective Evaluation of an Opioid-Free Protocol by Gridley et al. (J Endourol 2020;34(6):647–653;DOI: 10.1089/end.2019.0552)
Restricted accessOtherFirst published online June, 2020
Editorial Comment on: Enhanced Recovery After Surgery Protocol for Patients Undergoing Ureteroscopy: Prospective Evaluation of an Opioid-Free Protocol by Gridley et al. (J Endourol 2020;34(6):647–653;DOI: 10.1089/end.2019.0552)
Centers for Disease Control and Prevention. Wide-ranging online data for epidemiologic research (WONDER). Atlanta, GA: CDC, 2017. Accessed March27, 2020.
2.
HosierGW, McGregorT, BeikoD, et al.Persistent opioid use among patients with urolithiasis: A population based study. Eur Urol Focus, 2019 [Epub ahead of print]; DOI: 10.1016/j.euf.2019.08.011.
3.
GridleyC, RoblesJ, CalveryJ, et al.Enhanced recovery after surgery protocol for patients undergoing ureteroscopy: Prospective evaluation of an opiod-free protocol. J Endourol, 2020; 34:647–653.
4.
LargeT, HeimanJ, RossA, et al.Initial experience with narcotic-free ureteroscopy: A feasibility analysis. J Endourol, 2018; 32:907–911.
5.
SobelDW, CisuT, BarclayT, et al.A Retrospective review demonstrating the feasibility of discharging patients without opioids after ureteroscopy and ureteral stent placement. J Endourol, 2018; 32:1044–1049.
